Search Results

CDP Information & Policies

For information about other programs, click here. For information about applying for LLS research funding, click here. Grant Requirements Reporting Sc…

SCOR Information & Policies

For information about other programs, click here. For information about applying for LLS research funding, click here. Grant Requirements Reporting Sc…

TRP Information & Policies

For information about other programs, click here. For information about applying for LLS research funding, click here. Grant Requirements Reporting Sc…

National Cancer Institute's Cancer Information Service

To provide accurate, , and reliable information on cancer that is easy to understand; this free service is a federally funded cancer education program…

RTFCCR/LLS Prevention Information & Policies

For information about other programs, click here. For information about applying for LLS research funding, click here. Grant Requirements Reporting Sc…

Blood & Marrow Transplant Information Network (BMT InfoNet)

BMT InfoNet is dedicated to providing transplant patients, survivors and their loved ones with emotional support and high quality, information about …

Defining and Redefining a Blood Cancer Diagnosis

Science historian June Goodfield wrote, “Cancer begins and ends with people.” This Blood Cancer Awareness Month, it’s important to know that The Leu…

Balancing fiscal responsibility with saving and improving lives

Table of contents:Balancing Fiscal Responsibility with Saving and Improving LivesThe LLS Bold Goal: Accelerate Progress in Blood CancerLLS’s role in p…

CAR-T Immunotherapy Showing Positive Results

This week, positive data from a Kite Pharma immunotherapy clinical trial was released showing that more than of refractory aggressive lymphoma (NHL…

Welcome to Blood Cancer United

Things look a little different around here. The Leukemia & Lymphoma Society (LLS) has a new name: Blood Cancer United. You may be asking a question we…

A guide to Blood Cancer Awareness Month

Hope. When times are tough, it’s often hope people look for. We want things to work out, to see reasons to keep going. You hear “hope” a lot in conjun…

CureSearch for Children's Cancer

To fund and support targeted and innovative children's cancer research with measurable results, and be the authoritative source of information and res…

Lymphoma Foundation of America

To help lymphoma patients and families, and to fund research for a cure. Registered nurses provide medical information and resources Provides …

FAQs: Proposed federal spending cuts and blood cancer research and care

The Leukemia & Lymphoma Society (LLS) has heard great concerns from patients, caregivers, volunteers, healthcare professionals, researchers, community…

Another First: FDA Approves Car T-Immunotherapy for Treatment of Aggressive Form of Indolent Non-Hodgkin Lymphoma

The U.S. Food and Drug Administration (FDA) today approved the CAR treatment axicabtagene ciloleucel (Yescarta®) for patients with follicular lymphom…

Understanding Myeloma: A Quick Guide

Myeloma is a rare blood cancerLet’s address the elephant in the room. Myeloma is not a skin cancer—that’s melanoma. And it’s not a bone cancer—althoug…

Count on LLS this Blood Cancer Awareness Month

Close your eyes. Think of . million people. It’s hard, right? . million would fill every seat in approximately pro football stadiums. An average city…

Childhood Cancer Canada

To create victories for Canadian children with cancer through investment in national, collaborative, lifesaving research, empowering education and com…

Multiple Myeloma Research Foundation

To pursue innovative means that accelerate the development of multiple myeloma treatments to extend the lives of patients and lead to a cure. P…

New Drug Approval Moves Us Closer To Long-Term Control of Multiple Myeloma

Ciltacabtagene Autoleucel () is the second approved to treat multiple myeloma Just one year after the fir…

Ushering In a New Era of Pediatric Blood Cancer Treatment and Care

Breaking Down Barriers in Blood Cancer Care

When I meet blood cancer survivors and their families, they often share their personal stories with me. Sometimes they talk about the relief of findin…

FDA Approves First CAR T-Immunotherapy for Relapsed/Refractory Acute Lymphoblastic Leukemia

The U.S. Food and Drug Administration (FDA) recently announced approval of brexucabtagene autoleucel (Tecartus®) as the first and only CAR treatment …

Histiocytosis Association

Dedicated to raising awareness about histiocytic disorders, providing educational and emotional support, and funding research leading to better treatm…

Leukaemia Foundation of Australia

To fund research and to provide free services to support people with leukaemia, lymphoma, myeloma and related blood disorders, and their families in A…